Related content

Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 930-936

Spandidos Publications

Access to resources Recommend Favorite

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma - results of the MM87 prospective randomised protocol

By Riccardi A.   Mora O.   Tinelli C.   Porta C.   Danova M.   Brugnatelli S.   Grasso D.   Tolca B.   Spanedda R.   De Paoli A.   Barbarano L.   Cavanna L.   Giordano M.   Delfini C.   Nicoletti G.   Bergonzi C.   Rinaldi E.   Piccinini L.   Ascari E.   for the Cooperative Group of Study Treatment of Multiple Myeloma  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite

A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival

By Kowalska Maria  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 194-198

Humana Press, Inc

Access to resources Recommend Favorite

Retrospective analysis of 264 multiple myeloma patients

By                    

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 707-713

Spandidos Publications

Access to resources Recommend Favorite

Improvement in survival of patients with cancer of the kidney in Europe

By Damhuis R.A.M.   Kirkels W.J.  

European Journal of Cancer, Vol. 34, Iss. 14, 1998-12 ,pp. : 2232-2235

Elsevier

Access to resources Recommend Favorite